Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis ConferenceBusiness Wire • 10/09/26
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 10/05/26
Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?The Motley Fool • 10/04/26
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 10/01/26
Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?The Motley Fool • 10/01/26
2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.The Motley Fool • 09/29/26
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 09/24/26
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/24/26
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 09/22/26
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE TrialBusiness Wire • 09/22/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts AheadMarketBeat • 09/14/26
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/14/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/10/26